The schedule includes: RotaTeq (RV5): Administered as a series of three oral doses given at 2 months, 4 months, and 6 months ...
Since licensure in 2006, the rotavirus vaccines, RV5 (pentavalent bovine-human reassortant vaccine, Rotateq, Merck) and RV1 (attenuated monovalent human rotavirus vaccine, Rotarix, GSK Biologicals ...
Monitoring the health benefits of rotavirus vaccines in developing countries is important to document the performance of vaccines in these high-burden settings. For rotavirus vaccines to reach ...